Eli Lilly Portfolio Companies

Aktis Oncology is a biotechnology company that designs and develops novel class radiopharmaceuticals.

Basys.ai automates the process of prior authorization and utilization management for health plans/payers using an AI-based platform.

NanoSyrinx is a discovery stage biotechnology company based at the University of Warwick’s Medical School.

OrsoBio is a clinical-stage biopharmaceutical company that develops therapies to treat severe metabolic disorders.

Circle Pharma is a biotechnology company creating bioavailable macrocyclic peptide therapeutics that target protein-protein interactions.

RetiSpec is a medical imaging startup developing an eye scanner for early detection of Alzheimer’s Disease pathology.

Myricx Bio is a biotechnology company that develops novel NMT inhibitor payloads for ADCs to treat cancer.

Vanqua Bio is a biotechnology company that discovers and develops next-generation medicines for patients with neurodegenerative diseases.

Radar Therapeutics pioneer in treatment modality, precision-expressed mRNA-based therapeutics.

Lycia Therapeutics is a biotechnology company that focuses on developing technology that utilizes lysosome-targeting chimeras.

Blacksmith Medicines developing medicines targeting metal-dependent enzymes found in human physiology.

Firefly Bio specializes in Degrader Antibody Conjugates (DACs) which combine the unique strengths of ADCs with selective protein degraders.

ViaNautis is at the forefront of developing novel medications capable of crossing biological barriers.

Sitryx is a biopharmaceutical company develops disease modifying therapeutics in immuno-oncology and immuno-inflammation.

Mariana Oncology is a biotechnology research industry.

Amber Bio is a biotechnology company pioneering new gene editing modalities using multi-kilobase edits.

AltPep provides a novel approach for tackling amyloid diseases, with diagnostic, therapeutic and anti-biofilm applications.

Mozart is a biotech startup focusing on the development of disease-modifying therapies for autoimmune and inflammatory diseases.

Nido Biosciences is a clinical-stage company that develops precision medicines for severe neurological diseases.

DiogenX is a preclinical stage biotech company specializing in the development of pancreatic beta-cell modulators.

IgGenix is a biotechnology company.

Rimidi is a health IT platform that enables virtual, personalized management of cardiometabolic diseases.

Rezo Therapeutics identifies targets and therapies by combining distinct, unbiased technologies with artificial intelligence.

Jaguar Gene Therapy is accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases.

Arkuda Therapeutics is a pharmaceutical company.